Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/jspui/handle/10553/155459
| Title: | Perioperative pembrolizumab in early-stage non-small-cell lung cancer (NSCLC): 5-year follow-up from the KEYNOTE-671 global study and Asian subgroup | Authors: | Tsuboi, M. Wakelee, H. Spicer, J. D. Gao, S. Liberman, M. Kato, T. Chen, K-N. Dooms, C. Majem, M. Martinengo, G. L. Bylicki, O. Rodríguez Abreu, Delvys Halmos, B. Jones, D. R. Chaft, J. Reck, M. Jense, E. Keller, S. M. Samkari, A. Garassino, M. C. |
UNESCO Clasification: | 32 Ciencias médicas 320101 Oncología |
Issue Date: | 2025 | Journal: | Annals of Oncology | Conference: | ESMO Asia Congress 2025 | URI: | https://accedacris.ulpgc.es/jspui/handle/10553/155459 | ISSN: | 0923-7534 | DOI: | 10.1016/j.annonc.2025.10.607 | Source: | Annals Of Oncology[ISSN 0923-7534],v. 36 sup. 4, Abstract LBA9, p. 2079-2080 (Diciembre 2025) |
| Appears in Collections: | Actas de congresos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.